Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $33,925 | 6 | 98.9% |
| Food and Beverage | $387.44 | 9 | 1.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI US SERVICES INC. | $33,925 | 6 | $0 (2023) |
| Amgen Inc. | $100.00 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $89.90 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $87.04 | 1 | $0 (2018) |
| Lilly USA, LLC | $30.27 | 2 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $29.77 | 1 | $0 (2023) |
| LANTHEUS MEDICAL IMAGING, INC. | $26.50 | 1 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $12.09 | 1 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $11.87 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26.50 | 1 | LANTHEUS MEDICAL IMAGING, INC. ($26.50) |
| 2023 | $6,830 | 4 | SANOFI US SERVICES INC. ($6,800) |
| 2021 | $27,125 | 3 | SANOFI US SERVICES INC. ($27,125) |
| 2019 | $89.90 | 1 | E.R. Squibb & Sons, L.L.C. ($89.90) |
| 2018 | $87.04 | 1 | AstraZeneca Pharmaceuticals LP ($87.04) |
| 2017 | $154.23 | 5 | Amgen Inc. ($100.00) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/06/2024 | LANTHEUS MEDICAL IMAGING, INC. | — | Food and Beverage | In-kind items and services | $26.50 | General |
| 11/08/2023 | SANOFI US SERVICES INC. | — | — | Cash or cash equivalent | $525.00 | Research |
| Study: A Label Comprehension and Input Assessment Study for Cialis OTC Among Adult Males 18Years of Age and Older with an Interest in a Treatment for Erectile Dysfunction | ||||||
| 11/07/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug), OFEV | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2023 | SANOFI US SERVICES INC. | — | — | Cash or cash equivalent | $1,200.00 | Research |
| Study: A Label Comprehension and Input Assessment Study for Cialis OTC Among Adult Males 18Years of Age and Older with an Interest in a Treatment for Erectile Dysfunction | ||||||
| 03/04/2023 | SANOFI US SERVICES INC. | — | — | Cash or cash equivalent | $5,075.00 | Research |
| Study: LCS17775-A Label Comprehension and Input Assessment Study for Cialis OTC Among Adult Males 18Years of Age and Older with an Interest in a Treatment for Erectile Dysfunction | ||||||
| 12/29/2021 | SANOFI US SERVICES INC. | — | — | Cash or cash equivalent | $700.00 | Research |
| Study: A Purchase Qualification Study for Cialis OTC Among Adult Males 18 Years of Age or Older Who Are Seeking an OTC Treatment for Erectile Dysfunction | ||||||
| 11/23/2021 | SANOFI US SERVICES INC. | — | — | Cash or cash equivalent | $25,725.00 | Research |
| Study: A Purchase Qualification Study for Cialis OTC Among Adult Males 18 Years of Age or Older Who Are Seeking an OTC Treatment for Erectile Dysfunction | ||||||
| 08/30/2021 | SANOFI US SERVICES INC. | — | — | Cash or cash equivalent | $700.00 | Research |
| Study: A Purchase Qualification Study for Cialis OTC Among Adult Males 18 Years of Age or Older Who Are Seeking an OTC Treatment for Erectile Dysfunction | ||||||
| 09/19/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $89.90 | General |
| Category: Cardiovascular | ||||||
| 09/13/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $87.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/02/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/18/2017 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Diabetes | ||||||
| 06/28/2017 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Diabetes | ||||||
| 05/31/2017 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $100.00 | General |
| 05/16/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: GASTROENTEROLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Purchase Qualification Study for Cialis OTC Among Adult Males 18 Years of Age or Older Who Are Seeking an OTC Treatment for Erectile Dysfunction | SANOFI US SERVICES INC. | $27,125 | 3 |
| LCS17775-A Label Comprehension and Input Assessment Study for Cialis OTC Among Adult Males 18Years of Age and Older with an Interest in a Treatment for Erectile Dysfunction | SANOFI US SERVICES INC. | $5,075 | 1 |
| A Label Comprehension and Input Assessment Study for Cialis OTC Among Adult Males 18Years of Age and Older with an Interest in a Treatment for Erectile Dysfunction | SANOFI US SERVICES INC. | $1,725 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 12 | 12 | $1,644 | $801.64 |
| 2021 | 2 | 37 | 37 | $5,125 | $2,391 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 12 | $1,644 | $801.64 | 48.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 26 | $5,070 | $2,358 | 46.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 11 | 11 | $55.00 | $33.00 | 60.0% |
About Dr. Srinivas Boppana, D.O
Dr. Srinivas Boppana, D.O is a Family Medicine healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2012. The National Provider Identifier (NPI) number assigned to this provider is 1679839252.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Srinivas Boppana, D.O has received a total of $34,312 in payments from pharmaceutical and medical device companies, with $26.50 received in 2024. These payments were reported across 15 transactions from 9 companies. The most common payment nature is "" ($33,925).
As a Medicare-enrolled provider, Boppana has provided services to 49 Medicare beneficiaries, totaling 49 services with total Medicare billing of $3,193. Data is available for 2 years (2021–2023), covering 3 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Tampa, FL
- Active Since 04/08/2012
- Last Updated 11/22/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679839252
Products in Payments
- ELIQUIS (Drug) $89.90
- FARXIGA (Drug) $87.04
- TRULICITY (Drug) $30.27
- OFEV (Drug) $29.77
- JANUVIA (Drug) $12.09
- XIFAXAN (Drug) $11.87
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Tampa
Emily Horn, Pa, PA
Family Medicine — Payments: $151,588
Dr. Michael Nieder, M.d, M.D
Family Medicine — Payments: $102,257
Mr. Lon Lynn, D.o, D.O
Family Medicine — Payments: $34,536
Dr. Robert Mirsky, Md, MD
Family Medicine — Payments: $30,580
Dr. Maria Del Pilar Cekan, M.d, M.D
Family Medicine — Payments: $20,296
Dr. Dipali Patel
Family Medicine — Payments: $17,994